{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:38:00Z","timestamp":1784043480320,"version":"3.55.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170453"],"award-info":[{"award-number":["82170453"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Various cytokines were involved in the process of atherosclerosis, and their serum levels were correlated with coronary artery disease (CAD) to varying degrees. However, there were limited reports about the correlation between serum cytokines and the severity of coronary atherosclerotic lesion in patients with non-acute myocardial infarction (AMI). The purpose of this study was to investigate the relationship between serum cytokines and the severity of CAD, and identify the predictors of severe CAD in patients suspected to have CAD but AMI had been ruled out.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 502 patients who had suspected CAD and underwent coronary angiography were enrolled. The serum levels of IL-1\u03b2, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-17, TNF-\u03b1, IFN-\u03b1,and IFN-\u03b3 were determined by multiplexed particle-based flow cytometric assays technology. And the severity of CAD was evaluated by Gensini score (GS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The serum levels of IL-4, IL-12p70, IL-17, and IFN-\u03b1 were significantly lower in the severe CAD group (GS\u226530) than those in the non-severe CAD group (GS &amp;lt; 30). And IL-12p70 and IL-17 were negatively correlated with the severity of CAD. Multivariate logistic regression analyses demonstrated that two serum cytokines (IL-12p70 and IL-17), one clinical protective factor (HDL-C), and two clinical risk factors (gender and diabetes) were the independent predictors of severe CAD. ROC curve analysis showed that multivariate mode combined these predictors had a good performance in predicting severe CAD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The combination of serum cytokines (IL-12p70 and IL-17) and clinical risk factors (HDL-C, gender, and diabetes) may help identify patients with more severe coronary artery lesions from those with suspected CAD but not AMI, and may contribute to guiding the risk stratification for patients with chest discomfort in health care facilities without sufficient medical resources (especially cardiac catheterization resources).<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.896810","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T06:13:52Z","timestamp":1652681632000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Serum Cytokines Predict the Severity of Coronary Artery Disease Without Acute Myocardial Infarction"],"prefix":"10.3389","volume":"9","author":[{"given":"Sheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S0735-1097(03)00833-7","article-title":"Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease","volume":"42","author":"Vivekananthan","year":"2003","journal-title":"J Am Coll Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/CIRCULATIONAHA.120.049755","article-title":"Outcomes in the ISCHEMIA trial based on coronary artery disease and ischemia severity","volume":"144","author":"Reynolds","year":"2021","journal-title":"Circulation."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1172\/JCI97950","article-title":"The role of non-resolving inflammation in atherosclerosis","volume":"128","author":"Kasikara","year":"2018","journal-title":"J Clin Invest."},{"key":"B4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: pathogenic and regulatory pathways","volume":"86","author":"Tedgui","year":"2006","journal-title":"Physiol Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.immuni.2019.03.007","article-title":"Cytokine circuits in cardiovascular disease","volume":"50","author":"Williams","year":"2019","journal-title":"Immunity."},{"key":"B6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/000331970105200204","article-title":"Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction","volume":"52","author":"Balbay","year":"2001","journal-title":"Angiology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/09629350310001633360","article-title":"Levels of serum IL-1beta, IL-2, IL-8 and tumor necrosis factor-alpha in patients with unstable angina pectoris","volume":"12","author":"Ozeren","year":"2003","journal-title":"Mediators Inflamm."},{"key":"B8","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cca.2010.01.011","article-title":"Prognostic value of cytokines and chemokines in addition to the GRACE Score in non-ST-elevation acute coronary syndromes","volume":"411","author":"Correia","year":"2010","journal-title":"Clin Chim Acta Int J Clin Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ijcard.2005.09.001","article-title":"Cytokines in acute coronary syndromes","volume":"105","author":"Pasqui","year":"2005","journal-title":"Int J Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1182\/blood-2007-05-089086","article-title":"Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis","volume":"110","author":"Denny","year":"2007","journal-title":"Blood."},{"key":"B11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/09537100600800412","article-title":"Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina","volume":"18","author":"Avramakis","year":"2007","journal-title":"Platelets."},{"key":"B12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17\/Treg imbalance in patients with acute coronary syndrome","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin Immunol Orlando Fla."},{"key":"B13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4062\/biomolther.2010.18.2.135","article-title":"Interleukin-4, oxidative stress, vascular inflammation and atherosclerosis","volume":"18","author":"Lee","year":"2010","journal-title":"Biomol Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cellimm.2015.05.007","article-title":"The paradoxical role of IL-17 in atherosclerosis","volume":"297","author":"Gong","year":"2015","journal-title":"Cell Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0828-282X(07)70818-8","article-title":"Matrix metalloproteinases and myocardial infarction","volume":"23","author":"Phatharajaree","year":"2007","journal-title":"Can J Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/1074248412465015","article-title":"Rosuvastatin changes cytokine expressions in ischemic territory and preserves heart function after acute myocardial infarction in rats","volume":"18","author":"Hu","year":"2013","journal-title":"J Cardiovasc Pharmacol Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","article-title":"Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction","volume":"67","author":"Westman","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pharep.2018.09.007","article-title":"The relationships among monocyte subsets, miRNAs and inflammatory cytokines in patients with acute myocardial infarction","volume":"71","author":"Kazimierczyk","year":"2019","journal-title":"Pharmacol Rep PR."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cell.2019.02.015","article-title":"Genetics of common, complex coronary artery disease","volume":"177","author":"Musunuru","year":"2019","journal-title":"Cell."},{"key":"B21","doi-asserted-by":"publisher","first-page":"P27","DOI":"10.4244\/EIJV8SPA6","article-title":"ACS and STEMI treatment: gender-related issues","volume":"8","author":"Chieffo","year":"2012","journal-title":"EuroIntervention."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/ejhf.1831","article-title":"Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the acute heart failure committee of the heart failure association of the European society of cardiology","volume":"22","author":"Harjola","year":"2020","journal-title":"Eur J Heart Fail."},{"key":"B23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.atherosclerosis.2014.12.047","article-title":"Serum chemokine CCL17\/thymus activation and regulated chemokine is correlated with coronary artery diseases","volume":"238","author":"Ye","year":"2015","journal-title":"Atherosclerosis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00392-013-0555-4","article-title":"Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application","volume":"102","author":"Sinning","year":"2013","journal-title":"Clin Res Cardiol Off J Ger Card Soc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1134\/S0006297916110134","article-title":"The role of cytokines in the development of atherosclerosis","volume":"81","author":"Fatkhullina","year":"2016","journal-title":"Biochem Biokhimiia."},{"key":"B26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11010-017-3054-5","article-title":"Serum concentrations of MCP-1 and IL-6 in combination predict the presence of coronary artery disease and mortality in subjects undergoing coronary angiography","volume":"435","author":"Tajfard","year":"2017","journal-title":"Mol Cell Biochem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.clinbiochem.2015.02.002","article-title":"Relationship between serum cytokine and growth factor concentrations and coronary artery disease","volume":"48","author":"Mirhafez","year":"2015","journal-title":"Clin Biochem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.4049\/jimmunol.1400181","article-title":"IL-17A influences essential functions of the monocyte\/macrophage lineage and is involved in advanced murine and human atherosclerosis","volume":"193","author":"Erbel","year":"2014","journal-title":"J Immunol Baltim Md 1950"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4013685","DOI":"10.1155\/2017\/4013685","article-title":"Serum cytokine profile in relation to the severity of coronary artery disease","volume":"2017","author":"Min","year":"2017","journal-title":"BioMed Res Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12967-014-0214-1","article-title":"Is serum Interleukin-17 associated with early atherosclerosis in obese patients?","volume":"12","author":"Tarantino","year":"2014","journal-title":"J Transl Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1161\/ATVBAHA.111.229997","article-title":"Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice","volume":"32","author":"Danzaki","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/eurheartj\/ehs263","article-title":"Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction","volume":"34","author":"Simon","year":"2013","journal-title":"Eur Heart J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","article-title":"The immunobiology of the interleukin-12 family: room for discovery","volume":"50","author":"Tait Wojno","year":"2019","journal-title":"Immunity."},{"key":"B34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fphar.2020.00129","article-title":"Roles and mechanisms of interleukin-12 family members in cardiovascular diseases: opportunities and challenges","volume":"11","author":"Ye","year":"2020","journal-title":"Front Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"154188","DOI":"10.1016\/j.cyto.2017.10.010","article-title":"The IL-12 cytokine family in cardiovascular diseases","volume":"122","author":"van der Heijden","year":"2019","journal-title":"Cytokine."},{"key":"B36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5551\/jat1994.8.30","article-title":"Changes in serum interleukin-8 and interleukin-12 levels in patients with ischemic heart disease in a Chinese population","volume":"8","author":"Zhou","year":"2001","journal-title":"J Atheroscler Thromb."},{"key":"B37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1089\/met.2015.0130","article-title":"Combined elevated levels of the proinflammatory cytokines IL-18 and IL-12 are associated with clinical events in patients with coronary artery disease: an observational study","volume":"14","author":"Opstad","year":"2016","journal-title":"Metab Syndr Relat Disord."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/cvr\/cvy263","article-title":"Interleukin-12p35 knockout promotes macrophage differentiation, aggravates vascular dysfunction, and elevates blood pressure in angiotensin II-infused mice","volume":"115","author":"Ye","year":"2019","journal-title":"Cardiovasc Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1161\/ATVBAHA.118.311969","article-title":"Deficiency of IL12p40 (Interleukin 12 p40) promotes Ang II (Angiotensin II)-induced abdominal aortic aneurysm","volume":"39","author":"Sharma","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1194\/jlr.R051367","article-title":"Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review","volume":"55","author":"White","year":"2014","journal-title":"J Lipid Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"456","DOI":"10.2174\/1389201018666170630120805","article-title":"Biomarkers in stable coronary artery disease","volume":"18","author":"Rusnak","year":"2017","journal-title":"Curr Pharm Biotechnol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.896810\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T06:13:56Z","timestamp":1652681636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.896810\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":41,"alternative-id":["10.3389\/fcvm.2022.896810"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.896810","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"article-number":"896810"}}